In BEAS-2B cells, Tiotropium Bromide at 12.5 pg/mL significantly suppressed LPS-induced IL-8 production compared with its absence, whereas concentrations <10.0 pg/mL did not inhibit this response. In UNCN3T cells, Tiotropium Bromide at 5-50 μM produced no significant difference in mucin secretion compared with culture medium alone. At the same tested concentrations, no significant increase in IL-6 was observed in UNCN3T cells. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
LPS-Induced IL-8 Production in BEAS-2B Cells
Cell-based study · BEAS-2B cells [1]
BEAS-2B cells were treated with Tiotropium Bromide before LPS stimulation. Tiotropium Bromide at <10.0 pg/mL did not inhibit LPS-induced IL-8 production, whereas 12.5 pg/mL significantly suppressed it compared with the absence of Tiotropium Bromide.
Literature-Reported Treatment Conditions
- Treatment concentration
- <10.0 pg/mL; 12.5 pg/mL; >15.0 pg/mL
- Exposure duration
- 2 hours before the stimulation with LPS; for 24 hours
- Method
- added to cell cultures
- Vehicle
- MEDIUM
- Co-treatment
- Other interventions in this design: LPS 1.0 μg/mL. Compound effect isolated by the comparison: in the presence or absence of tiotropium bromide.
Methods and source locations
Compound reported in the paper: Tiotropium Bromide
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Chemicals (S4); Materials and methods > Cell culture (S26); Results > Suppressive activity of tiotropium bromide on IL-8 production from cells after LPS stimulation (S42, S43, S44)
IL-8 levels in culture supernatants were assayed by ELISA: IL-8 levels in culture supernatants were assayed by ELISA; comparator: absence of tiotropium bromide — Results > Suppressive activity of tiotropium bromide on IL-8 production from cells after LPS stimulation (S42, S43)
Mucin secretion in UNCN3T cells
Cell-based study · UNCN3T cells cultured on Geltrex™-coated plastic; n = 12 (n = 4 in triplicate; three experiments performed on different days) [2]
UNCN3T cells cultured on Geltrex™-coated plastic were incubated with Tiotropium Bromide at 5-50 μM for 30 min. Mucin secretion did not differ significantly from the response to culture medium alone.
Literature-Reported Treatment Conditions
- Treatment concentration
- 5-50 μM
- Exposure duration
- 30 min
- Method
- incubated for 30 min at 37 °C 5% CO2/95% air in control or drug solutions
- Vehicle
- LHC basal medium
Methods and source locations
Compound reported in the paper: Tiotropium Bromide
Evidence for Tiotropium Bromide as the hydrate form reported in the paper, not the free base/neutral form supplied as A10934; no salt equivalence, dose conversion or lot validation.
Materials and methods > Quantification of cytokine release and mucus secretion in response to treatment with inhaled drugs (S101, S102); Results > The effects of some inhaled drugs on mucus secretion from SPOC1 and UNCN3T cells (S205); Fig. 9 legend (S231, S233)
mucin secretion: mucin secretion; comparator: culture medium alone — Materials and methods > Quantification of cytokine release and mucus secretion in response to treatment with inhaled drugs (S102); Results > The effects of some inhaled drugs on mucus secretion from SPOC1 and UNCN3T cells (S205); Fig. 9 legend (S231)
IL-6 responses in UNCN3T cells
Cell-based study · UNCN3T cells cultured on Geltrex™-coated plastic; n = 12 (4 replicates; three independent experiments) [2]
UNCN3T cells cultured on Geltrex™-coated plastic were incubated with Tiotropium Bromide at 5-50 μM for 30 min. No significant increase in IL-6 was observed compared with cells exposed to culture medium alone.
Literature-Reported Treatment Conditions
- Treatment concentration
- 5-50 μM
- Exposure duration
- 30 min
- Method
- incubated for 30 min at 37 °C 5% CO2/95% air in control or drug solutions
- Vehicle
- LHC basal medium
Methods and source locations
Compound reported in the paper: Tiotropium Bromide
Evidence for Tiotropium Bromide as the hydrate form reported in the paper, not the free base/neutral form supplied as A10934; no salt equivalence, dose conversion or lot validation.
Materials and methods > Quantification of cytokine release and mucus secretion in response to treatment with inhaled drugs (S101, S102); Results > The effects of some inhaled drugs on cytokine release from SPOC1 and UNCN3T cells (S180, S192, S193); Fig. 8 legend (S228, S230)
IL-6: IL-6; comparator: cells exposed to culture medium alone — Materials and methods > Quantification of cytokine release and mucus secretion in response to treatment with inhaled drugs (S102); Results > The effects of some inhaled drugs on cytokine release from SPOC1 and UNCN3T cells (S180, S193)